| Lic Mf Healthcare Fund Datagrid | ||||||
|---|---|---|---|---|---|---|
| Category | Pharma Fund | |||||
| BMSMONEY | Rank | N/A | ||||
| Rating | N/A | |||||
| Growth Option 04-12-2025 | ||||||
| NAV | ₹29.58(R) | -0.12% | ₹32.43(D) | -0.12% | ||
| Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
| Lumpsum | Regular | -3.49% | -% | -% | -% | -% |
| Direct | -2.3% | -% | -% | -% | -% | |
| Nifty Pharma TRI | 3.12% | 21.61% | 14.04% | 15.04% | 7.75% | |
| SIP (XIRR) | Regular | 4.21% | -% | -% | -% | -% |
| Direct | 5.49% | -% | -% | -% | -% | |
| Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
| Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
| Fund AUM | As on: 30/06/2025 | 84 Cr | ||||
| Top Pharma Fund | |||||
|---|---|---|---|---|---|
| Fund Name | Rank | Rating | |||
| Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | - | ||||
| Sbi Healthcare Opportunities Fund | - | ||||
NAV Date: 04-12-2025
| Scheme Name | NAV | Rupee Change | Percent Change |
|---|---|---|---|
| LIC MF Healthcare Fund-Regular Plan-Growth | 29.58 |
-0.0400
|
-0.1200%
|
| LIC MF Healthcare Fund-Regular Plan-IDCW | 29.58 |
-0.0400
|
-0.1200%
|
| LIC MF Healthcare Fund-Direct Plan-Growth | 32.43 |
-0.0400
|
-0.1200%
|
| LIC MF Healthcare Fund-Direct Plan-IDCW | 32.43 |
-0.0400
|
-0.1200%
|
Review Date: 04-12-2025
Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.
Data Source: www.amfiindia.com
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | -1.67 | 2.81 |
-1.01
|
-1.79 | -0.09 | 11 | 12 | Poor |
| 3M Return % | 0.25 | 4.79 |
0.09
|
-1.09 | 1.13 | 6 | 13 | Good |
| 6M Return % | 4.81 | 7.96 |
4.26
|
-1.94 | 8.01 | 5 | 13 | Good |
| 1Y Return % | -3.49 | 3.12 |
-0.50
|
-7.34 | 5.07 | 10 | 13 | Average |
| 1Y SIP Return % | 4.21 |
3.34
|
-25.71 | 10.70 | 8 | 13 | Good |
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | -1.57 | 2.81 | -0.91 | -1.66 | -0.01 | 11 | 12 | Poor |
| 3M Return % | 0.55 | 4.79 | 0.41 | -0.84 | 1.47 | 6 | 13 | Good |
| 6M Return % | 5.46 | 7.96 | 4.93 | -1.15 | 8.94 | 5 | 13 | Good |
| 1Y Return % | -2.30 | 3.12 | 0.79 | -5.81 | 6.47 | 11 | 13 | Average |
| 1Y SIP Return % | 5.49 | 4.69 | -24.55 | 12.63 | 9 | 13 | Average |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
| Date | Lic Mf Healthcare Fund NAV Regular Growth | Lic Mf Healthcare Fund NAV Direct Growth |
|---|---|---|
| 04-12-2025 | 29.576 | 32.4343 |
| 03-12-2025 | 29.5542 | 32.4093 |
| 02-12-2025 | 29.6129 | 32.4726 |
| 01-12-2025 | 29.6973 | 32.5641 |
| 28-11-2025 | 29.9266 | 32.8122 |
| 27-11-2025 | 29.8013 | 32.6737 |
| 26-11-2025 | 29.9305 | 32.8142 |
| 25-11-2025 | 29.6951 | 32.555 |
| 24-11-2025 | 29.5982 | 32.4477 |
| 21-11-2025 | 29.666 | 32.5187 |
| 20-11-2025 | 29.859 | 32.7292 |
| 19-11-2025 | 29.9223 | 32.7975 |
| 18-11-2025 | 29.9211 | 32.795 |
| 17-11-2025 | 30.1612 | 33.0571 |
| 14-11-2025 | 30.0864 | 32.9718 |
| 13-11-2025 | 29.9554 | 32.8271 |
| 12-11-2025 | 29.9837 | 32.857 |
| 11-11-2025 | 29.7539 | 32.6042 |
| 10-11-2025 | 29.8665 | 32.7264 |
| 07-11-2025 | 29.7449 | 32.5898 |
| 06-11-2025 | 29.8841 | 32.7413 |
| 04-11-2025 | 30.0792 | 32.9528 |
| Fund Launch Date: 28/Feb/2019 |
| Fund Category: Pharma Fund |
| Investment Objective: The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. There is no assurance that the investment objective of the Scheme will be achieved. |
| Fund Description: An open-ended equity scheme investing in Healthcare and Allied sectors |
| Fund Benchmark: BSE Healthcare- TRI |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.